; (B) by striking Free and inserting 3.1% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (28) Azoxystrobin Heading 9902.06.30 is amended— (A) by amending the article description to read as follows: Methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4- yl]oxy}phenyl)-3-methoxyacrylate (Azoxystrobin) (CAS No. 131860–33–8) (provided for in subheading 2933.59.15) ; (B) by striking 6.2% and inserting 5.9% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (29) DEDS Heading 9902.06.41 is amended— (A) by amending the article description to read as follows: 5-Ethoxy-2-[(5-ethoxy-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)disulfanyl]-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidine (CAS No. 166524–75–0) (provided for in subheading 2933.59.70) ; (B) by striking 0.6% and inserting 5% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (30) Spirotetramat Heading 9902.06.67 is amended— (A) by amending the article description to read as follows: [3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl] ethyl carbonate (Spirotetramat) (CAS No. 203313–25–1) (provided for in subheading 2933.79.08) ; (B) by striking 3.2% and inserting 1% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (31) Cyproconazole Heading 9902.06.77 is amended— (A) by amending the article description to read as follows: [α-(4-Chlorophenyl)-α-(1-cyclopropylethyl)-1H-1-1,2,4- triazole-1-ethanol (Cyproconazole) (CAS No. 94361–06–5) (provided for in subheading 2933.99.22) ; (B) by striking Free and inserting 1.3% ; and (C) by striking 12/31/2020 and inserting 12/31/2025 . (32) Tebuconazole Heading 9902.06.78 is amended— (A) by amending the article description to read as follows: (RS)-1-p-Chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1- ylmethyl)pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 2933.99.22) ; (B) by striking Free and inserting 4.4%